Skip to main content
logo
Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
2.840
+0.030 (1.07%)
At close: Jul 2, 2026, 4:00 PM EDT
2.860
+0.020 (0.70%)
After-hours: Jul 2, 2026, 7:59 PM EDT

Aurora Cannabis Revenue

In the fiscal year ending March 31, 2026, Aurora Cannabis had annual revenue of 320.59M CAD with 10.97% growth. Aurora Cannabis had revenue of 38.01M in the quarter ending March 31, 2026, with 5.14% growth.

Revenue (ttm)
320.59M CAD
Revenue Growth
+10.97%
P/S Ratio
0.77
Revenue / Employee
311,861 CAD
Employees
1,028
Market Cap
176.85M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026320.59M31.68M10.97%
Mar 31, 2025288.91M19.27M7.15%
Mar 31, 2024269.64M45.83M20.48%
Mar 31, 2023223.80M2.47M1.11%
Jun 30, 2022221.34M-23.91M-9.75%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Organogenesis Holdings514.70M
Akebia Therapeutics232.40M
Organigram Global196.43M
Lifecore Biomedical129.46M
Anika Therapeutics116.26M
SIGA Technologies93.78M
Journey Medical64.68M
Cumberland Pharmaceuticals41.94M
Revenue Rankings

ACB News

More News